Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Review1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- J Toxicol Environ Health1
Search Results
Sort by
- Bookedited by Slobodan Vukicevic, Kuber T. Sampath.Contents:
Historical perspective of bone morphogenetic proteins
The systems biology of bone morphogenetic proteins
Embryonic skeletogenesis and craniofacial development
BMP and BMP regulation: structure and function
Novel in vitro assay models to study osteogenesis and chondrogenesis for human skeletal disorders
Toward advanced therapy medicinal products (ATMPs) combining bone morphogenetic proteins (BMP) and cells for bone regeneration
BMP signaling in articular cartilage repair and regeneration: potential therapeutic opportunity for osteoarthritis
BMPs in orthopaedic medicine: promises and challenges
Osteogrow: a novel graft substitute for orthopedic reconstruction
Biology of spine fusion and application of osteobiologics in spine surgery
BMPs in dental medicine: promises and challenges
Bone morphogenetic protein-7 and its role in acute kidney injury and chronic kidney failure
Bone morphogenetic protein signaling in pulmonary arterial hypertension
BMP signaling in fibrodysplasia ossificans progressiva, a rare genetic disorder of heterotopic ossification
The central role of BMP signaling in regulating iron homeostasis
BMPs in inflammation
Physiological and pathological consequences of vascular BMP signaling
Bone morphogenetic proteins in the initiation and progression of breast cancer. - ArticleChu EH, Trosko JE, Chang CC.J Toxicol Environ Health. 1977 Jul;2(6):1317-34.A number of circumstantial lines of evidence are consistent with the somatic mutation theory of carcinogenesis, but there has been a paucity of experimental data that either support or contradict the genetic theory. In this paper, we summarize the predictions, the recent experimental approaches, and the problems involved in testing the theory. Results are presented that define the conditions and demonstrate the existence of two-stage processes of mutagenesis and carcinogenesis in vitro. We conclude that mutagenesis is responsible for the initiation of carcinogenesis and an epigenetic mechanism is responsible for its promotion. Carcinogenic agents can induce a stable transformation of a cell by either mutation or epigenetic alteration in gene expression. This conclusion has led us to propose a new integrative theory of carcinogenesis, encompassing the tenets of four main theories: (1) the mutation and epigenetic basis for carcinogenesis, (2) the two-stage theory of carcinogenesis, (3) a general theory of carcinogenesis, and (4) the somatic deletion mutation theory of carcinogenesis.